The Caring for Carcinoid Foundation, a nonprofit organization that funds research to discover cures for neuroendocrine cancers, has changed its name to the Neuroendocrine Tumor Research Foundation, and launched a new brand and website.
The 2015 Scripps 12th Annual Natural Supplements Conference awarded First, Second and Third Place honors for scientific posters to Medicus Research, the global contract research organization that specializes in the study of natural health products.
Extension of grant from the Bill & Melinda Gates Foundation to facilitate community engagement in TB drug development; education for regulatory scientists.
After a year of reviewing the research, consulting with experts, and engaging leading immunotherapy centers, the Caring for Carcinoid Foundation is thrilled to announce the launch of a major immunotherapy initiative for neuroendocrine cancer. A treatment that uses the body's own immune system to fight cancer, immunotherapy has led to dramatic results for some patients with other forms of cancer.
Nephrologists are working towards an improved understanding of how to prevent the progression of kidney disease. Dr. Scott Brimble MD FRCPC will discuss potential new therapies for polycystic kidney disease (PKD) and polycystic liver disease.
Gamry Instruments is proud to be an exhibitor at the 65th Annual Meeting of the International Society of Electrochemistry entitled Ubiquitous Electrochemistry.
Join us at this DIFFERENTIATED & FOCUSED conference on "BIOPLASTICS" and get updated on how traditional polymers as well as newer materials are being developed from renewable food / non-food biomass; a radical shift from petroleum based industry.
While government health sites remain behind the times, Clinical Trials GPS provides patients with up to date trial and facility data, new patient dashboard and study promotion tools for research sites.
Achieve is conducting a randomized, single-dose study comparing the efficacy and safety of a combination of acetaminophen and aspirin vs placebo in the acute treatment of migraine headaches.
Achieve is conducting a study to evaluate the safety and efficacy of a new drug versus rituximab in patients with moderately to severely active rheumatoid arthritis (RA).
Achieve Clinical Research is conducting a randomized clinical study to evaluate the safety, tolerability, and efficacy of a new drug for the treatment of opioid-induced constipation in adults taking opioid therapy for chronic non-cancer pain.
The Southwood Group are advising clients on A.P Moeller-Maersk A/S as the world's largest shipping line announces rising earnings forecasts for the year.
Satisfied Users & 
Approved Press Releases
